Clover Biopharmaceuticals selects GE’s biomanufacturing platform

The new facility will support a robust pipeline of biopharmaceuticals, including a biosimilar to Enbrelâ for the treatment of rheumatoid arthritis

picture of

Breaking News

Synpromics UCL partnership to develop novel gene therapies

Synpromics, a specialist in gene control, announced a collaboration with UCL Great Ormond Street Institute of Child ...

CBMG accelerates cell therapy manufacturing

GE Healthcare’s new start-to-finish solution — FlexFactory — for cell therapy installation will provide Cellular ...

CGT Catapult collaborates with Freeline Therapeutics

Cell and Gene Therapy Catapult (CGT Catapult) has teamed up with Freeline Therapeutics to further develop its ...

Gene transfer therapy approved for the treatment of ALL: part II

In August 2017, Novartis received FDA approval for its chimeric antigen receptor T (CAR-T) cell therapy, Kymriah, for ...

X-Chem collaborates with AstraZeneca

Small molecule discovery specialist X-Chem, announced a significant expansion of its existing global drug discovery ...

CPhI Japan predicts a transformative year for Japanese pharma

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma, as the market evolves ...

Performance validation: HPAPI containment testing in a risk-based era

Taking a more automated approach to validation testing paves the way to capturing more repeatable and reliable data, ...

Abzena develops new facilities in Cambridge, UK and San Diego

Abzena, the life sciences group providing services and technologies to enable the development and manufacture of ...

Aslan announces shortened timeline to commercialisation for varlitinib

Aslan Pharmaceuticals announced that commercialisation of varlitinib in China, if approved, is expected to begin ...

Regenerative medicine and the benefits of cell-based combinatorial screening technology

Although many technical challenges remain ahead, regenerative medicine has the potential to profoundly change the way ...

Gene transfer therapy approved for the treatment of ALL: part I

In August 2017, Novartis received FDA approval for its chimeric antigen receptor T (CAR-T) cell therapy, Kymriah, for ...

Revolutionising toxicogenomics with big data

Genestack CEO, Dr Misha Kapushesky, explains how metadata can unlock pharmaceutical assay results for deeper analysis

Biocrates Life Sciences acquires Metanomics Health

Biocrates Life Sciences, a global leader in targeted metabolomics, announced the acquisition of Metanomics Health a ...

FDA moves to accept high throughput sequencing to identify viral contamination

Results of FDA study supports development of high throughput sequencing for viral safety evaluation of biologic ...